HAXBY GROUP PRACTICE — All Prescriptions & Medications — Page 16
Practice Code: B82026 | YORK, YO32 2LL
Showing results 751-800 of 885
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Tube feed 1 kcal/ml with fibre (0914021) | 16 | 250.0K | £5.8K | +72.3% ▲ |
| Tube feed 1.5 kcal/ml peptide based (0914032) | 16 | 386.0K | £8.2K | +66.8% ▲ |
| Triamcinolone acetonide | 16 | 16 | £113 | +56.2% ▲ |
| Pilocarpine hydrochloride | 16 | 1,596 | £744 | +48.9% ▲ |
| Other barrier preparations | 16 | 570 | £60 | +170.4% ▲ |
| 16 | 69 | £223 | -51.2% ▼ | |
| 16 | 39 | £3.4K | +94.3% ▲ | |
| 16 | 470 | £183 | -28.3% ▼ | |
| 16 | 570 | £1.7K | +57.1% ▲ | |
| Mebeverine hydrochloride compound preparations | 15 | 610 | £531 | +32.7% ▲ |
| Prednisolone sodium metasulphobenzoate | 15 | 28 | £9.6K | +279.8% ▲ |
| Heparin flushes | 15 | 136 | £264 | +324.1% ▲ |
| Diphenhydramine hydrochloride | 15 | 412 | £105 | +15.5% ▲ |
| Riluzole | 15 | 952 | £4.7K | +44.5% ▲ |
| Drospirenone | 15 | 1,260 | £210 | +133.1% ▲ |
| Fesoterodine fumarate | 15 | 420 | £35 | -62.0% ▼ |
| Ready to serve 3.3 kcal/ml higher protein dessert (0913141) | 15 | 50.5K | £1.2K | +149.0% ▲ |
| Clindamycin phosphate | 15 | 660 | £162 | -8.8% ▼ |
| 15 | 295 | £584 | -65.9% ▼ | |
| 15 | 840 | £1.1K | +53.3% ▲ | |
| 15 | 1,440 | £1.0K | +107.3% ▲ | |
| 15 | 1,950 | £207 | -29.1% ▼ | |
| 15 | 1,200 | £5.6K | +171.3% ▲ | |
| 15 | 450 | £671 | +130.6% ▲ | |
| Dronedarone hydrochloride | 14 | 796 | £887 | -3.1% ▼ |
| Ciprofibrate | 14 | 392 | £991 | +4.8% ▲ |
| Glycopyrronium bromide | 14 | 600 | £523 | -62.4% ▼ |
| Mometasone/glycopyrronium/indacaterol | 14 | 420 | £592 | -7.6% ▼ |
| Doxylamine succinate/pyridoxine hydrochloride | 14 | 600 | £855 | +26.9% ▲ |
| Ofloxacin | 14 | 394 | £598 | +70.4% ▲ |
| Liquid additive lactase (0913121) | 14 | 462 | £527 | +231.1% ▲ |
| Tube feed 1.5 kcal/ml (0914011) | 14 | 175.0K | £3.1K | +43.0% ▲ |
| Ketorolac trometamol | 14 | 70 | £44 | +50.9% ▲ |
| Fluticasone propionate (Topical) | 14 | 450 | £61 | +289.1% ▲ |
| 14 | 164 | £280 | +155.9% ▲ | |
| 14 | 426 | £870 | -49.7% ▼ | |
| 14 | 690 | £1.2K | +92.1% ▲ | |
| 14 | 14 | £177 | +58.3% ▲ | |
| 14 | 360 | £1.3K | +83.1% ▲ | |
| Clonidine hydrochloride | 13 | 364 | £29 | -28.8% ▼ |
| Methyldopa | 13 | 728 | £154 | -23.7% ▼ |
| Rutosides | 13 | 728 | £161 | +0.4% vs avg |
| Ciclesonide | 13 | 13 | £257 | -11.7% ▼ |
| Levocetirizine | 13 | 936 | £122 | -16.6% ▼ |
| Lormetazepam | 13 | 585 | £196 | +10.4% ▲ |
| Moclobemide | 13 | 1,560 | £461 | +0.4% vs avg |
| Atomoxetine hydrochloride | 13 | 364 | £710 | -61.6% ▼ |
| Acamprosate calcium | 13 | 2,184 | £243 | -62.7% ▼ |
| Alogliptin/metformin | 13 | 728 | £329 | -68.8% ▼ |
| Canagliflozin | 13 | 364 | £453 | -90.9% ▼ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.